Bristol-Myers Squibb Company (BMS) is an American multinational biopharmaceutical company headquartered in Princeton, New Jersey. Formed by the 1989 merger of Bristol-Myers and Squibb, it focuses on the discovery, development, manufacturing, and marketing of innovative medicines for serious diseases.
The company operates in key therapeutic areas including oncology, hematology, immunology, cardiovascular, and neuroscience. Leading products include Eliquis (apixaban) for atrial fibrillation, Opdivo (nivolumab) for cancer immunotherapy, Revlimid (lenalidomide) for multiple myeloma, Orencia (abatacept) for autoimmune conditions, and Reblozyl (luspatercept) for anemia. BMS is publicly traded on the NYSE under the ticker BMY and maintains a global presence with facilities worldwide.
To provide comprehensive coverage, we aggregate data and news under the name BMS, encompassing the following company names, divisions, and related entities:
Bristol Myers Squibb and Bristol-Myers Squibb.
This list encompasses current and former names, alternate names, and key divisions associated with BMS, ensuring you can easily find all relevant information under a single, unified profile.
